The study of the epigenetic mechanisms that ensure the correct propagation of transcriptional states throughout the cell cycle is important for understanding lineage commitment and cellular reprogramming. The hematopoietic transcription factor GATA1, an acetylated protein, is essential for the differentiation and commitment of several hematopoietic lineages. We recently found that GATA1 interacts with the bromodomain protein Brd3 in an acetylation-dependent manner in vitro and in vivo. Anti-Brd3 ChIP-seq analysis showed that GATA1 is a key determinant of Brd3 recruitment in interphase cells in vivo. Notably, we found that Brd3, like some other Brd family proteins, remains bound to chromatin during mitosis when the vast majority of nuclear factors are removed from chromatin. Brd3 binding might thus provide an epigenetic memory function to """"""""bookmark"""""""" genes in a manner that facilitates the appropriated re-assembly transcription factor complexes at the correct sites upon re-entry into the G1 phase of the cell cycle.
In Aim 1, we will study the function of Brd3 in hematopoietic development, and biochemically and structurally dissect the Brd3-GATA1 interaction. We will determine the in vivo acetylation sites of GATA1 and monitor acetylation dynamics during the cell cycle and at varying stages of cell growth and differentiation.
In Aim 2 we will examine the genome-wide occupancy pattern of Brd3 in mitosis and define the mechanisms of mitotic and interphase Brd3 recruitment. We will examine whether Brd3 serves a bookmarking function of hematopoietic genes and study how Brd3 transmits transcriptional information through mitosis. This will involve the testing of Brd3-occupied elements in gain-of- function assays at the single allele level in living cells and the targeted destruction of Brd3 specifically during mitosis.
In Aim 3 the in vivo function of Brd3 will be assessed by conditional deletion in mice. Together, the proposed studies are designed to elucidate the transcriptional and epigenetic machinery that underlies the establishment and stable propagation of gene expression patterns in the hematopoietic system.
The proposed studies are aimed to better understand the mechanisms underlying the formation of the blood lineages and their associated disorders. Our work focuses on how nuclear factors and their chemical modifications control the genes that govern the specification and differentiation of blood cells. Progress in this area promises novel approaches to treat blood-related disorders including leukemias and anemias.
|Stonestrom, Aaron J; Hsu, Sarah C; Werner, Michael T et al. (2016) Erythropoiesis provides a BRD's eye view of BET protein function. Drug Discov Today Technol 19:23-28|
|Edwards, Christopher R; Ritchie, William; Wong, Justin J-L et al. (2016) A dynamic intron retention program in the mammalian megakaryocyte and erythrocyte lineages. Blood :|
|Stonestrom, Aaron J; Hsu, Sarah C; Jahn, Kristen S et al. (2015) Functions of BET proteins in erythroid gene expression. Blood 125:2825-34|
|Hsiung, Chris C-S; Morrissey, Christapher S; Udugama, Maheshi et al. (2015) Genome accessibility is widely preserved and locally modulated during mitosis. Genome Res 25:213-25|
|Campbell, Amy E; Hsiung, Chris C-S; Blobel, Gerd A (2014) Comparative analysis of mitosis-specific antibodies for bulk purification of mitotic populations by fluorescence-activated cell sorting. Biotechniques 56:90-1, 93-4|
|Deng, Wulan; Blobel, Gerd A (2014) Manipulating nuclear architecture. Curr Opin Genet Dev 25:1-7|
|Wu, Weisheng; Morrissey, Christapher S; Keller, Cheryl A et al. (2014) Dynamic shifts in occupancy by TAL1 are guided by GATA factors and drive large-scale reprogramming of gene expression during hematopoiesis. Genome Res 24:1945-62|
|Pimkin, Maxim; Kossenkov, Andrew V; Mishra, Tejaswini et al. (2014) Divergent functions of hematopoietic transcription factors in lineage priming and differentiation during erythro-megakaryopoiesis. Genome Res 24:1932-44|
|Blobel, Gerd A; Hardison, Ross C (2013) A cluster to remember. Cell 154:718-20|
|Hardison, Ross C; Blobel, Gerd A (2013) Genetics. GWAS to therapy by genome edits? Science 342:206-7|
Showing the most recent 10 out of 42 publications